Globe Life CEO sells 20,000 shares after option exercise
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
GLOBE LIFE INC. Co-Chairman & CEO Frank M. Svoboda reported a two-day exercise-and-sell pattern in common stock. On June 11–12, 2026, he exercised employee stock options to acquire a total of 20,000 shares of common stock at an exercise price of $100.74 per share.
Over the same period, he executed open-market sales totaling 20,000 shares at weighted-average prices around the mid‑$160s per share, with individual trades occurring in ranges from $163.935 to $167.425 per share, as disclosed in footnotes. After these transactions, he directly held 54,020.4648 shares of common stock.
The filing also reports indirect holdings as of June 11, 2026, including 1,955.294 shares in a 401(k) plan, 26,425 shares in a spouse’s irrevocable trust, 5,000 shares in an irrevocable trust, and 103,473 shares in a family trust.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Employee Stock Option (Right to Buy) | 10,000 | $0.00 | $0.00 |
| Exercise | Common Stock | 10,000 | $100.74 | $1.01M |
| Sale | Common Stock | 4,366 | $166.3642 | $726K |
| Sale | Common Stock | 5,634 | $166.9311 | $940K |
| Exercise | Employee Stock Option (Right to Buy) | 10,000 | $0.00 | $0.00 |
| Exercise | Common Stock | 10,000 | $100.74 | $1.01M |
| Sale | Common Stock | 2,630 | $164.1955 | $432K |
| Sale | Common Stock | 7,370 | $165.1256 | $1.22M |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
Footnotes (5)
- F1. Reporting person will provide full information regarding the number of shares sold at each separate price upon request by the SEC staff, the issuer or any security holder of the issuer.
- F2. Sales at prices ranging from $163.935 per share to $164.885 per share.
- F3. Sales at prices ranging from $164.91 per share to $165.355 per share.
- F4. Sales at prices ranging from $165.635 per share to $166.595 per share.
- F5. Sales at prices ranging from $166.605 per share to $167.425 per share.
AI-generated analysis. How Rhea-AI works. Not financial advice.